Everett Harris & Co. CA Cuts Holdings in Fresenius Medical Care AG & Co. (NYSE:FMS)

Everett Harris & Co. CA trimmed its holdings in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,559 shares of the company’s stock after selling 3,275 shares during the period. Everett Harris & Co. CA’s holdings in Fresenius Medical Care AG & Co. were worth $2,169,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of FMS. First Trust Advisors LP increased its stake in Fresenius Medical Care AG & Co. by 12.5% in the first quarter. First Trust Advisors LP now owns 86,559 shares of the company’s stock worth $3,508,000 after purchasing an additional 9,624 shares during the period. NEXT Financial Group Inc purchased a new stake in Fresenius Medical Care AG & Co. in the second quarter worth $29,000. Landsberg Bennett & Dubbaneh LLC purchased a new stake in Fresenius Medical Care AG & Co. in the second quarter worth $285,000. Confluence Investment Management LLC increased its stake in Fresenius Medical Care AG & Co. by 2.7% in the second quarter. Confluence Investment Management LLC now owns 21,328 shares of the company’s stock worth $838,000 after purchasing an additional 556 shares during the period. Finally, Lindbrook Capital LLC increased its stake in Fresenius Medical Care AG & Co. by 163.0% in the second quarter. Lindbrook Capital LLC now owns 781 shares of the company’s stock worth $30,000 after purchasing an additional 484 shares during the period. 1.52% of the stock is owned by institutional investors and hedge funds.

A number of analysts have weighed in on the company. Royal Bank of Canada reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, August 19th. BTIG Research lowered Fresenius Medical Care AG & Co. from a “buy” rating to a “neutral” rating in a research note on Thursday, August 1st. ValuEngine lowered Fresenius Medical Care AG & Co. from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Redburn Partners restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Wednesday, October 23rd. Finally, DZ Bank restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Wednesday, October 30th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $45.81.

Shares of Fresenius Medical Care AG & Co. stock traded down $0.41 during trading on Wednesday, hitting $36.14. 174,588 shares of the stock traded hands, compared to its average volume of 224,910. The firm has a market cap of $22.78 billion, a P/E ratio of 15.92, a price-to-earnings-growth ratio of 3.75 and a beta of 1.46. The company has a current ratio of 0.98, a quick ratio of 0.75 and a debt-to-equity ratio of 0.75. Fresenius Medical Care AG & Co. has a 52-week low of $30.99 and a 52-week high of $42.75. The stock’s fifty day simple moving average is $34.21 and its 200 day simple moving average is $36.43.

About Fresenius Medical Care AG & Co.

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: How is the LIBOR rate calculated?

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.